• Wed. Nov 25th, 2020

Covid-19 Vaccine Study Results Could Come Late October, Moderna CEO Says – The Wall Street Journal

A large, pivotal study of Moderna Inc.’s Covid-19 vaccine could yield a preliminary answer about whether the shot works safely as early as October, though it’s more likely to be November, the company’s leader said.

Moderna Chief Executive Stephane Bancel said in an interview the timing will depend on rates of infection in the U.S. locations where the trial is being conducted, because the study is comparing whether fewer vaccinated people come down with symptomatic Covid-19 than unvaccinated people.